Marfan syndrome is caused by mutations in the FBN1 gene, which carries the instructions for making fibrillin-1. Fibrillin-1 is a protein that forms the scaffolding of connective tissue throughout the body. When FBN1 is mutated, that scaffolding is weak, and the result is a condition that affects the heart, eyes, bones, and blood vessels. In most people with Marfan syndrome, the mutation is inherited from a parent. In roughly one in four cases, the mutation is new — it appears for the first time in that person and was not inherited from either parent.
What Type Of Mutation Causes Marfan Syndrome?
FBN1 mutations are typically small changes scattered along the gene. Most are what geneticists call point mutations or small insertions and deletions — a single letter of DNA swapped, added, or removed. These changes alter how the fibrillin-1 protein is built or processed.
What makes Marfan unusual is that the mutation is usually dominant. A person needs only one altered copy of FBN1 to develop the condition. The other copy is normal, but it is not enough to compensate. This is why Marfan syndrome can pass from parent to child with a 50% chance for each pregnancy.
There is no single “Marfan mutation.” Hundreds of different FBN1 changes have been reported in affected families. Two people with Marfan syndrome may carry entirely different mutations, yet have overlapping features. The specific mutation does not reliably predict how severe the condition will be, even within the same family.
The dominant-negative mechanism
Fibrillin-1 molecules link together to form microfibrils, the thread-like fibers that give connective tissue its elasticity and strength. A mutated fibrillin-1 protein can interfere with the assembly of these fibers. It acts like a faulty brick that disrupts the whole wall, not just the spot where it sits. This is called a dominant-negative effect, and it helps explain why one bad copy causes problems even when the other copy works normally.
Some FBN1 mutations instead cause the protein to be broken down or not produced at all. These are called haploinsufficiency mutations. Research suggests the two mechanisms may produce somewhat different clinical pictures, though the evidence is not strong enough to guide individual care.
Is Marfan Syndrome Always Inherited?
No. About one in four cases of Marfan syndrome result from a new mutation, called a de novo mutation. In these cases, neither parent carries the mutation in their blood, and there is usually no family history of the condition.
A de novo mutation happens in the sperm or egg cell that formed the pregnancy, or very early in development. It is not caused by anything the parents did or did not do. This matters because parents sometimes blame themselves when a child is diagnosed with a genetic condition and there is no family history. In Marfan syndrome, that blame is misplaced.
There is one important exception. A parent can carry the mutation in a small fraction of their reproductive cells only, a situation called germline mosaicism. In that case, the parent’s blood test may be normal, but the mutation can still be passed to more than one child. This is uncommon but real, and it is one reason genetic counseling is recommended for families planning more children.
What Does the FBN1 Gene Actually Do?
FBN1 sits on chromosome 15 and provides the blueprint for fibrillin-1. Fibrillin-1 is one of the main building blocks of microfibrils, which are found in skin, blood vessels, lungs, the lens of the eye, and the walls of the aorta.
Microfibrils do more than provide physical support. They also store and release growth factors, including transforming growth factor beta (TGF-beta). When fibrillin-1 is abnormal, TGF-beta signaling can become excessive. Some researchers believe this overactive signaling contributes to problems like aortic root enlargement and lung changes in Marfan syndrome. This has become an active area of research and has influenced thinking about possible treatments, though it remains an area of ongoing study rather than settled fact.
The connective tissue weakness explains the classic features. The aorta stretches and weakens because its wall lacks normal elastic fibers. The lens of the eye can shift because the fibers holding it in place are loose. Bones grow longer than usual for reasons that are not fully understood.
How Does a Marfan Mutation Affect the Body?
The effects of an FBN1 mutation are wide-ranging because connective tissue is everywhere. The most serious concern is the aorta, the large artery that carries blood from the heart. In Marfan syndrome, the aortic root can widen over time, and this widening raises the risk of an aortic dissection — a tear in the artery wall that is a medical emergency.
Other features include:
- Tall stature and unusually long arms, legs, fingers, and toes
- A curved spine (scoliosis) or a chest that caves in or pushes out
- Nearsightedness and dislocation of the lens of the eye
- Flexible joints and flat feet
- Stretch marks not explained by weight change or pregnancy
Not everyone has every feature. Some people are mildly affected; others have serious heart involvement. Because the mutation does not predict severity, regular monitoring is the standard approach regardless of how mild the condition seems at first.
How Is Marfan Syndrome Diagnosed?
Diagnosis combines a physical exam, family history, imaging of the heart and aorta, and genetic testing. A cardiologist typically evaluates the aorta with echocardiography, and an eye exam can detect lens dislocation.
Genetic testing can confirm a suspected diagnosis by identifying an FBN1 mutation. It is not always necessary. Some people are diagnosed on clinical grounds alone when they have a clear pattern of features. Genetic testing is most useful when the picture is unclear, when family members want to know their own status, or when parents are considering future pregnancies.
One clarification worth making: Marfan syndrome is not the only condition caused by FBN1 changes, and not every FBN1 variant causes Marfan syndrome. Some variants cause related but distinct conditions, and some are harmless. This is why genetic test results need interpretation by a genetics professional, not a quick online lookup.
What About Related Connective Tissue Conditions?
Several conditions look similar to Marfan syndrome but have different genetic causes. Loeys-Dietz syndrome and vascular Ehlers-Danlos syndrome can both involve aortic problems and are caused by mutations in other genes. Distinguishing them matters because the risks and monitoring differ.
There is also a group of conditions sometimes called “Marfan-like” or MASS phenotype, where some features overlap but the aorta is less involved. These distinctions require careful evaluation. A person who is tall with long fingers does not automatically have Marfan syndrome, and the reverse is also true — some people with Marfan syndrome are not unusually tall.
Can a Marfan Mutation Be Prevented or Treated?
No treatment can correct the FBN1 mutation itself. Gene editing for Marfan syndrome is not available and is not close to clinical use. What exists is monitoring and management aimed at preventing complications.
Regular imaging of the aorta allows doctors to track widening and intervene before a crisis. Blood pressure control is a central part of care, and some medications are used to reduce stress on the aortic wall. When the aorta reaches a certain size, surgery to replace the aortic root may be recommended. The exact threshold for surgery is a clinical decision made with a specialist and depends on several factors.
Physical activity guidance is individualized. Heavy lifting and certain competitive sports that involve straining or collision are generally discouraged because they raise blood pressure sharply, but the specifics should come from the treating team. This is not a condition to manage alone.
Anyone with Marfan syndrome or a family history should be evaluated by a cardiologist familiar with connective tissue disorders. The evidence for close monitoring is strong. The evidence for any single drug strategy is less settled, and patients should expect their care team to weigh the options rather than follow a one-size-fits-all plan.
Frequently Asked Questions
Is Marfan syndrome caused by a single gene mutation?
Yes. Marfan syndrome is caused by mutations in the FBN1 gene on chromosome 15, which makes the protein fibrillin-1. Hundreds of different mutations in this one gene can cause the condition.
Can Marfan syndrome skip a generation?
It generally does not skip generations in the usual sense, because the mutation is dominant and a parent with it has a 50% chance of passing it on. However, a parent with a mild or undiagnosed case can pass it to a child, and a new mutation can appear with no family history at all.
If I have Marfan syndrome, will my child have it?
Each child has a 50% chance of inheriting the mutation if you carry it. That is the chance per pregnancy, not a guarantee, and genetic counseling can help you understand your specific situation.
Can Marfan syndrome be cured with gene therapy?
No. Gene therapy for Marfan syndrome is not available, and no treatment currently corrects the underlying FBN1 mutation. Care focuses on monitoring the aorta and managing complications.

